Pacira BioSciences, Inc. (PCRX) Q3 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Pacira Biosciences, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:05.137 Good day, and thank you for standing by. Welcome to the Pacera Biosciences third quarter 00:00:05.137 -- 00:00:10.563 earnings conference call. At this time, all participants are in a listen-only mode. 00:00:10.563 -- 00:00:14.427 After the speaker's presentation, there will be a question and answer session. 00:00:14.427 -- 00:00:19.072 To ask a question during the session, you will need to press star 11 on your telephone. 00:00:19.072 -- 00:00:22.857 You will then hear an automated message advising that your hand is raised. 00:00:22.857 -- 00:00:25.860 To withdraw your question, please press star 11 again. 00:00:25.860 -- 00:00:30.254 Please be advised that today's conference is being recorded. 00:00:30.254 -- 00:00:34.739 I would now like to hand the conference over to your first speaker today, Susan Mesko. 00:00:34.739 -- 00:00:37.159 Please go ahead. 00:00:37.722 -- 00:00:42.346 Thank you. Good afternoon, everyone. Welcome to today's conference call to discuss our 00:00:42.346 -- 00:00:47.411 third quarter 2025 financial results. Joining me are Frank Lee, 00:00:47.411 -- 00:00:52.637 Chief Executive Officer, Brendan Thien, Chief Commercial Officer, and Sean Cross, 00:00:52.637 -- 00:00:57.582 Chief Financial Officer. Jonathan Slonin, our Chief Medical Officer, is also here for 00:00:57.582 -- 00:01:02.501 our question and answer session. Before we begin, let me remind you that this call will 00:01:02.501 -- 00:01:08.048 include forward-looking statements subject to the safe harbor provisions of federal securities 00:01:08.048 -- 00:01:13.254 laws. Such statements represent our judgment as of today and may involve 00:01:13.254 -- 00:01:18.820 risks and uncertainties. This may cause our actual results, performance, or achievement...